Alizee Grimm Email & Phone Number
@chuv.ch
LinkedIn matched
Who is Alizee Grimm? Overview
A concise factual answer block for searchers comparing this professional profile.
Alizee Grimm is listed as Project Leader, Analytical Method Development at Cellula Therapeutics SA, based in Lausanne, Vaud, Switzerland. AeroLeads shows a work email signal at chuv.ch and a matched LinkedIn profile for Alizee Grimm.
Alizee Grimm previously worked as Senior Research Associate/ Chargée de Recherche at Chuv | Lausanne University Hospital and Postdoctoral Research Assistant at Chuv | Lausanne University Hospital. Alizee Grimm holds Doctor Of Philosophy (Ph.D.), Bioengineering And Biomedical Engineering from Ecole Polytechnique Fédérale De Lausanne.
Email format at Cellula Therapeutics SA
This section adds company-level context without repeating Alizee Grimm's masked contact details.
AeroLeads found 1 current-domain work email signal for Alizee Grimm. Compare company email patterns before reaching out.
About Alizee Grimm
Alizee Grimm is a Project Leader, Analytical Method Development at Cellula Therapeutics SA. She possess expertise in biomedical engineering, stem cells, molecular biology, protein engineering, bioengineering and 19 more skills. She is proficient in German, Italian and English.
Listed skills include Biomedical Engineering, Stem Cells, Molecular Biology, Protein Engineering, and 20 others.
Alizee Grimm's current company
Company context helps verify the profile and gives searchers a useful next step.
Alizee Grimm work experience
A career timeline built from the work history available for this profile.
Senior Research Associate/ Chargée De Recherche
Center of Experimental Therapeutics, Department of Oncology.-Coordinate and supervise translational research projects of internal phase I cell therapy trials from the Tumor Microenvironment and Biomarker Discovery HiTIDE lab.- Research in immuno-oncology: dissect mechanisms of T cell exclusion and immune-resistance in the tumor microenvironment for next generation adoptive cell therapy development.
Postdoctoral Research Assistant
Center of Experimental Therapeutics, Department of Oncology.- Data analysis and quality control of immunological assays for internal pre-clinical/clinical studies.- Research in immuno-oncology: dissect mechanisms of T cell exclusion and immune-resistance in the tumor microenvironment for next generation adoptive cell therapy development.
Scientist, Exploratory Bioresearch
- Evaluation of novel technologies and initiation of collaborations with companies in the field of cancer diagnostic & monitoring in liquid biopsy- Scientific support to the Personalized Medicine department for pre-clinical drug development and biomarker discovery
Visting Phd Student
Institute of Molecular Engineering. P.I: Prof. Jeffrey Alan Hubbell. - Relocation of the laboratory, technology transfer and training of PhD students- Design of a novel platform for induction of antigen-specific immune tolerance through targeting of the antigen to apoptotic cells scavenger receptors
Phd Student In Immunoengineering
Laboratory of Regenerative Medicine and Pharmacobiology, Merck Serono Chair in Drug Delivery. P.I: Prof. Jeffrey Alan Hubbell.Thesis in the applied immuno-engineering research field.In collaboration with laboratory technicians, chemists and bioengineers:- Participated to the development of an innovative antigen-specific immunotherapy. Engineered protein constructs, designed methods and protocols to assess the potential of the technology for treatment of autoimmunity, understand the mechanisms involved in this process and characterize the state of tolerance induced- Helped on the design of a co-adjuvanted vaccine for treatment of chronic hepatitis B and cancer
Master Thesis, Griffith Lab (Mit)
Institute of Bioengineering, MIT. PI: Professor Linda Griffith. "Phenotypic response of human mesenchymal stem cells to bivalent ErbB ligands". - Evaluated the phenotypic response of human mesenchymal stem cells exposed to bivalent ErbB ligands, aiming at enhancing bone differentiation.
Master In Bioengineering
Laboratory of Biomedical Orthopaedics, EPFL. P.I: Professor Dominique Pioletti.Development of a gel form of ECM-scaffold prepared from bovine Nucleus Pulposus for application in joint repair.
Alizee Grimm education
Doctor Of Philosophy (Ph.D.), Bioengineering And Biomedical Engineering
Master’S Degree, Bioengineering
Frequently asked questions about Alizee Grimm
Quick answers generated from the profile data available on this page.
What company does Alizee Grimm work for?
Alizee Grimm works for Cellula Therapeutics SA.
What is Alizee Grimm's role at Cellula Therapeutics SA?
Alizee Grimm is listed as Project Leader, Analytical Method Development at Cellula Therapeutics SA.
What is Alizee Grimm's email address?
AeroLeads has found 1 work email signal at @chuv.ch for Alizee Grimm at Cellula Therapeutics SA.
Where is Alizee Grimm based?
Alizee Grimm is based in Lausanne, Vaud, Switzerland while working with Cellula Therapeutics SA.
What companies has Alizee Grimm worked for?
Alizee Grimm has worked for Cellula Therapeutics Sa, Chuv | Lausanne University Hospital, Debiopharm International Sa, The University Of Chicago, and Epfl (École Polytechnique Fédérale De Lausanne).
How can I contact Alizee Grimm?
You can use AeroLeads to view verified contact signals for Alizee Grimm at Cellula Therapeutics SA, including work email, phone, and LinkedIn data when available.
What schools did Alizee Grimm attend?
Alizee Grimm holds Doctor Of Philosophy (Ph.D.), Bioengineering And Biomedical Engineering from Ecole Polytechnique Fédérale De Lausanne.
What skills is Alizee Grimm known for?
Alizee Grimm is listed with skills including Biomedical Engineering, Stem Cells, Molecular Biology, Protein Engineering, Bioengineering, Immunology, Pharmacokinetics, and Cell Biology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial